Biosimilar Newsletter Archive

  1. 01.02.20 -- Biosimilar Experts Highlight 2019 Triumphs, Tribulations 1/2/2020
    01/02/20 Biosimilar Development Newsletter
  2. 12.19.19 -- Biosimilar Development Top 10 Of 2019 12/19/2019
    12/19/19 Biosimilar Development Newsletter
  3. 12.12.19 -- Biosimilars: Not Just Big Pharma's Playground 12/12/2019
    12/12/19 Biosimilar Development Newsletter
  4. 12.06.19 -- Forging The Path For Efficient And Economical Viral Vector Production 12/6/2019
    12/06/19 Biosimilar Development Newsletter
  5. 12.05.19 -- EMA Shares Biosimilar Bright Spots, Challenges 12/5/2019
    12/05/19 Biosimilar Development Newsletter
  6. 11.27.19 -- WHO Elaborates Upon Biosimilar Prequalification Progress 11/27/2019
    11/27/19 Biosimilar Development Newsletter
  7. 11.21.19 -- 9 Bills That Could Impact Biologic Patent Disputes 11/21/2019
    11/21/19 Biosimilar Development Newsletter
  8. 11.19.19 -- Process Development: New Ways To Improve PD Efficiency And Process Outcome 11/19/2019
    11/19/19 Biosimilar Development Newsletter
  9. 11.14.19 -- Incentivizing U.S. Biosimilar Use In Oncology 11/14/2019
    11/14/19 Biosimilar Development Newsletter
  10. 11.11.19 -- cGMP Bioprocessing Regulatory Roadmap: Changes, Challenges, And Considerations 11/11/2019
    11/11/19 Biosimilar Development Newsletter